- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00605202
Effect of Licorice and Hydrochlorothiazide on Plasma Potassium
December 10, 2009 updated by: University of Oulu
This clinical trial is designed to study the effect of the combination of licorice and hydrochlorothiazide on plasma potassium levels in volunteers.
In one arm, 10 healthy volunteers will be given 32 grams of licorice a day together with a 25 mg dose of daily hydrochlorothiazide for 14 days.
This combination is compared with 32 grams of licorice a day for 14 days given in the other arm.
The study is a randomized, open-label cross-over trial.
There is at least a 3-week wash-out between the arms.
The hypothesis is that the combination of licorice and hydrochlorothiazide will cause hypokalemia.
The main outcome measure is the change in the plasma level of potassium between the arms.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Oulu, Finland, 90220
- Oulu University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 38 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy volunteer
- Age 18-40 years
Exclusion Criteria:
- Any continuous medication
- Any significant disease
- Hypotension or hypertension
- Allergy to licorice or hydrochlorothiazide
- Pregnancy and breast feeding
- Fear of needles and previous difficult blood samplings
- Substance abuse
- Participation in another clinical drug trial within 1 month of enrollment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Licorice
|
Licorice candy 32 grams a day for 14 days.
Other Names:
|
Active Comparator: Licorice and HCTZ
|
Hydrochlorothiazide 25 mg a day for 14 days.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Plasma Potassium
Time Frame: Baseline and 2 weeks
|
Plasma potassium measured with indirect ion specific electrode method
|
Baseline and 2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Markku Savolainen, MD, Oulu University Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2008
Primary Completion (Actual)
January 1, 2009
Study Completion (Actual)
January 1, 2009
Study Registration Dates
First Submitted
January 17, 2008
First Submitted That Met QC Criteria
January 29, 2008
First Posted (Estimate)
January 30, 2008
Study Record Updates
Last Update Posted (Estimate)
December 15, 2009
Last Update Submitted That Met QC Criteria
December 10, 2009
Last Verified
December 1, 2009
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Lakritsi ja hypokalemia
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypokalemia
-
Aga Khan UniversityUnknownAcute HypokalemiaPakistan
-
Duke UniversityCompletedBorderline HypokalemiaUnited States
-
National Defense Medical Center, TaiwanCompletedHypokalemia | HyperkalemiaTaiwan
-
University of OuluOulu University HospitalCompletedHyponatremia | Dehydration | Hypokalemia | HypernatremiaFinland
-
Indiana University School of MedicineCompletedIdiopathic Hypercalciuria | Hypokalemia Caused by Thiazide DiureticsUnited States
-
Phramongkutklao College of Medicine and HospitalUnknown
-
Seoul Medical CenterCompletedGeneral Anesthesia | Laparoscopic CholecystectomyKorea, Republic of
-
Baptist Health South FloridaTerminatedHypokalemiaUnited States
-
Centre Hospitalier Régional Metz-ThionvilleCompleted
-
AstraZenecaFudan UniversityCompletedHeart Failure | Hypokalemia | HyperkalemiaChina
Clinical Trials on Licorice
-
University of Veterinary and Animal Sciences, Lahore...Not yet recruitingPolycystic Ovary Syndrome | Metabolic Syndrome
-
Cairo UniversityUnknown
-
HaEmek Medical Center, IsraelUnknownDiabetes Mellitus | AtherosclerosisIsrael
-
Shiraz University of Medical SciencesCompletedAcute StrokeIran, Islamic Republic of
-
Linkoeping UniversityRecruiting
-
University of NebraskaTerminatedAsthma | Dental CariesUnited States
-
F&C Licorice LtdUnknownVaginal Dryness | Postmenopausal SymptomsIsrael
-
Medical University of ViennaThe Cleveland ClinicCompletedPain, Postoperative | Surgery, OralAustria
-
Egyptian Biomedical Research NetworkCompleted